Auswahl der wissenschaftlichen Literatur zum Thema „Neuropsychiatric fluctuations“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Neuropsychiatric fluctuations" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Neuropsychiatric fluctuations"
Magalhães, Andreia D., Deborah Amstutz, Katrin Petermann, Ines Debove, Mário Sousa, Marie E. Maradan-Gachet, Martin Lenard Lachenmayer et al. „Subthalamic stimulation has acute psychotropic effects and improves neuropsychiatric fluctuations in Parkinson’s disease“. BMJ Neurology Open 6, Nr. 1 (Januar 2024): e000524. http://dx.doi.org/10.1136/bmjno-2023-000524.
Der volle Inhalt der QuelleFox, Susan H., Naomi Visanji, Gaby Reyes, Philippe Huot, Jordi Gomez-Ramirez, Tom Johnston und Jonathan M. Brotchie. „Neuropsychiatric Behaviors in the MPTP Marmoset Model of Parkinson’s Disease“. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 37, Nr. 1 (Januar 2010): 86–95. http://dx.doi.org/10.1017/s0317167100009707.
Der volle Inhalt der QuelleAbbes, Marie, Eugénie Lhommée, Stéphane Thobois, Hélène Klinger, Emmanuelle Schmitt, Amélie Bichon, Anna Castrioto et al. „Subthalamic stimulation and neuropsychiatric symptoms in Parkinson’s disease: results from a long-term follow-up cohort study“. Journal of Neurology, Neurosurgery & Psychiatry 89, Nr. 8 (07.02.2018): 836–43. http://dx.doi.org/10.1136/jnnp-2017-316373.
Der volle Inhalt der QuelleSchmitt, Emmanuelle, Paul Krack, Anna Castrioto, Helene Klinger, Amelie Bichon, Eugénie Lhommée, Pierre Pelissier et al. „The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A Pilot Study“. Movement Disorders Clinical Practice 5, Nr. 3 (23.03.2018): 265–72. http://dx.doi.org/10.1002/mdc3.12607.
Der volle Inhalt der QuelleMatar, Elie, Simon R. White, John-Paul Taylor, Alan Thomas, Ian G. McKeith, Joseph P. M. Kane, Ajenthan Surendranathan, Glenda M. Halliday, Simon J. G. Lewis und John T. O'Brien. „Progression of Clinical Features in Lewy Body Dementia Can Be Detected Over 6 Months“. Neurology 97, Nr. 10 (17.08.2021): e1031-e1040. http://dx.doi.org/10.1212/wnl.0000000000012450.
Der volle Inhalt der QuelleZimmer, Eduardo R., Maxime J. Parent, Antoine Leuzy, Antonio Aliaga, Arturo Aliaga, Luc Moquin, Esther S. Schirrmacher et al. „Imaging in Vivo Glutamate Fluctuations with [11C]ABP688: A GLT-1 Challenge with Ceftriaxone“. Journal of Cerebral Blood Flow & Metabolism 35, Nr. 7 (25.03.2015): 1169–74. http://dx.doi.org/10.1038/jcbfm.2015.35.
Der volle Inhalt der QuelleDonaghy, Paul C., John-Paul Taylor, John T. O'Brien, Nicola Barnett, Kirsty Olsen, Sean J. Colloby, Jim Lloyd, George Petrides, Ian G. McKeith und Alan J. Thomas. „Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies“. Psychological Medicine 48, Nr. 14 (24.01.2018): 2384–90. http://dx.doi.org/10.1017/s0033291717003956.
Der volle Inhalt der QuelleKrouse, Adam, Huihua Li, Joseph A. Krenzer und William Nicholas Rose. „Plasmapheresis, Rituximab, and Ceftriaxone Provided Lasting Improvement for a 27-Year-Old Adult Male with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS)“. Case Reports in Psychiatry 2021 (02.11.2021): 1–4. http://dx.doi.org/10.1155/2021/8697902.
Der volle Inhalt der QuelleInfante, Roberto, Emmanuelle Schmitt, Sara Meoni, Valerie Fraix, Amelie Bichon, Andrea Kistner, Pierre Pelissier, Bettina Debu und Elena Moro. „Effects of subthalamic deep brain stimulation on neuropsychiatric fluctuations in patients with Parkinson's disease (psychostim study)“. Journal of the Neurological Sciences 429 (Oktober 2021): 117639. http://dx.doi.org/10.1016/j.jns.2021.117639.
Der volle Inhalt der QuelleOliveira, S. G., S. M. Pereira und J. Mendes. „Dementia in Parkinson's disease: Case report“. European Psychiatry 26, S2 (März 2011): 846. http://dx.doi.org/10.1016/s0924-9338(11)72551-2.
Der volle Inhalt der QuelleDissertationen zum Thema "Neuropsychiatric fluctuations"
Schmitt, Emmanuelle. „Qualification et quantification des fluctuations neuropsychiatriques dans la maladie de Parkinson : Validation d'un auto-questionnaire grenoblois“. Electronic Thesis or Diss., Université Grenoble Alpes, 2023. http://www.theses.fr/2023GRALS060.
Der volle Inhalt der QuelleParkinson's disease (PD) is the second most common neurodegenerative disorder. For many years, it has been described as a neuropsychiatric disease, due to its clinical expression which combines motor and non-motor symptoms, particularly psychological and emotional. During the course of PD, non-motor fluctuations appear and have a major negative impact on patients' autonomy and quality of life. Of these, neuropsychiatric fluctuations (NPsyF) are probably the most disabling. NPsyF are characterized by the alternation of the so-called OFF "hypo-dopaminergic" phase, characterized by anxiety, fatigue, lack of motivation, sadness and slowness of thought, and appearing during periods of reduced efficacy of antiparkinsonian treatment (OFF phase) ; and so-called ON "hyper-dopaminergic" phase, characterized by a general feeling of well-being, elevated mood (even hypomania), and hyperactivity; appearing during periods of antiparkinsonian treatment efficacy (ON phase). The presence and severity of NPsyF can vary from patient to patient. The identification and management of NPsyF play an essential role in the global and personalized management of PD. With this in mind, our group developed a neuropsychiatrics fluctuations scale (the NFS) a few years ago. This scale aims at defining and quantifying the impact of MPsyF on real time.The main aim of this thesis work is to study the psychometric characteristics of the NFS (NFS Pre-Valid and NFS-Valid studies), and secondarily, to use the NFS to study the clinical properties of fluctuating parkinsonian patients. We also analyzed the impact of deep brain stimulation treatment on NPsyF measured with NFS (PSYCHOStim Study)
Buchteile zum Thema "Neuropsychiatric fluctuations"
Zhou, Yuan, Kun Wang, Yong Liu, Ming Song, Sonya W. Song und Tianzi Jiang. „Spontaneous Low-Frequency Fluctuation Observed with Functional Magnetic Resonance Imaging as a Potential Biomarker in Neuropsychiatric Disorders“. In Advances in Cognitive Neurodynamics (II), 47–57. Dordrecht: Springer Netherlands, 2010. http://dx.doi.org/10.1007/978-90-481-9695-1_7.
Der volle Inhalt der QuelleRamirez-Zamora, Adolfo. „Acute Neuropsychiatric Symptoms and Impulse Control Disorders After Subthalamic Nucleus Deep Brain Stimulation“. In Deep Brain Stimulation, herausgegeben von Laura S. Surillo Dahdah, Padraig O’Suilleabhain, Hrishikesh Dadhich, Mazen Elkurd, Shilpa Chitnis und Richard B. Dewey, 149–54. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780190647209.003.0031.
Der volle Inhalt der QuelleHuang, Xiaohong, Xiaohua Li und Heng-Wei Cheng. „Gestational Tryptophan Fluctuation Underlying Ontogenetic Origin of Neuropsychiatric Disorders“. In Personality Traits - The Role in Psychopathology [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.106421.
Der volle Inhalt der QuelleManschreck, Christopher, Yesne Alici und William Breitbart. „Delirium in the Terminally Ill“. In Handbook of Psychiatry in Palliative Medicine 3rd edition, herausgegeben von Harvey Max Chochinov und William Breitbart, 77—C6.P129. 3. Aufl. Oxford University Press, 2022. http://dx.doi.org/10.1093/med/9780197583838.003.0006.
Der volle Inhalt der QuelleDavis, Daniel, Sarah Richardson und Esteban Sepulveda. „Delirium“. In Oxford Textbook of Neurologic and Neuropsychiatric Epidemiology, herausgegeben von Carol Brayne, Valery L. Feigin, Lenore J. Launer und Giancarlo Logroscino, 259–66. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198749493.003.0026.
Der volle Inhalt der QuelleTrzepacz, Paula, und Roos van der Mast. „The neuropathophysiology of delirium“. In Delirium in Old Age, 51–90. Oxford University PressNew York, NY, 2002. http://dx.doi.org/10.1093/oso/9780192632753.003.0004.
Der volle Inhalt der QuelleAlici, Yesne, und William S. Breitbart. „Delirium“. In Psycho-Oncology, herausgegeben von William S. Breitbart, 345–54. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780190097653.003.0045.
Der volle Inhalt der QuelleAlici, Yesne, Soenke Boettger und William S. Breitbart. „Delirium and Cognitive Impairment“. In Psycho-Oncology in Palliative and End of Life Care, 94—C5.P124. Oxford University PressNew York, 2022. http://dx.doi.org/10.1093/med/9780197615935.003.0005.
Der volle Inhalt der QuelleJyonouchi, Harumi, und Lee Geng. „Associations between Monocyte Cytokine Profiles and Co-Morbid Conditions in Autism Spectrum Disorders“. In Autism Spectrum Disorder - Profile, Heterogeneity, Neurobiology and Intervention. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.95548.
Der volle Inhalt der QuelleBerichte der Organisationen zum Thema "Neuropsychiatric fluctuations"
Wang, Xiaoyu. Pediatric TuiNa for Tourette syndrome in children: A systematic review and meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2023. http://dx.doi.org/10.37766/inplasy2023.4.0077.
Der volle Inhalt der Quelle